Serum SERPINA3 as a Candidate Non-Invasive Biomarker for Neuromyelitis Optica Spectrum Disorder: Proteomic Discovery and Same-Center Validation.

Xu T, Han B, Zheng G, Jiang W, Zhang H, Zhang G

Open source

DOI
10.3390/diagnostics16162660
Published
2026 Aug 20
Container
Diagnostics (Basel, Switzerland)
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/diagnostics16162660,
  title = {Serum SERPINA3 as a Candidate Non-Invasive Biomarker for Neuromyelitis Optica Spectrum Disorder: Proteomic Discovery and Same-Center Validation.},
  author = {Xu T and Han B and Zheng G and Jiang W and Zhang H and Zhang G},
  year = {2026},
  journal = {Diagnostics (Basel, Switzerland)},
  doi = {10.3390/diagnostics16162660},
  url = {https://doi.org/10.3390/diagnostics16162660}
}

RIS

TY  - JOUR
TI  - Serum SERPINA3 as a Candidate Non-Invasive Biomarker for Neuromyelitis Optica Spectrum Disorder: Proteomic Discovery and Same-Center Validation.
AU  - Xu T
AU  - Han B
AU  - Zheng G
AU  - Jiang W
AU  - Zhang H
AU  - Zhang G
PY  - 2026
JO  - Diagnostics (Basel, Switzerland)
DO  - 10.3390/diagnostics16162660
UR  - https://doi.org/10.3390/diagnostics16162660
ER  - 

APA

T, X., B, H., G, Z., W, J., H, Z., & G, Z. (2026). Serum SERPINA3 as a Candidate Non-Invasive Biomarker for Neuromyelitis Optica Spectrum Disorder: Proteomic Discovery and Same-Center Validation.. Diagnostics (Basel, Switzerland). https://doi.org/10.3390/diagnostics16162660

Source records